Physiological characteristics of patients with schizophrenia prematurely dying from circulatory diseases

Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists
Pao-Huan ChenChiao-Chicy Chen

Abstract

Patients with schizophrenia before reaching geriatric age are at high risk of circulatory mortality. However, investigations are lacking on the characteristics of physiological measurement among these at-risk patients. In this study, we followed acutely inpatients with schizophrenia disorder for cause of death through record linkage to the Death Certification System in Taiwan. Cases of patients who died because of circulatory morbidity (ICD-9 401-443) before turning 65 years old were used. Each schizophrenia case was then matched with two mentally healthy controls for the age and sex, and date of laboratory examination. Clinical data of all subjects were obtained by reviewing medical records. Totally, 81 patients with schizophrenia who died from circulatory diseases at mean ages of 48.0 ± 10.7 years were investigated. The mean age at the final acute psychiatric hospitalization was 43.0 ± 10.9 years. Multivariate analysis showed that elevated fasting serum glucose levels (95% confidence interval [CI] for odds ratio (OR) = 1.00-1.03), blood leukocyte counts (95% CI for odds ratio (OR) = 1.07-1.55), and heart rates on electrocardiogram (95% CI for OR = 1.04-1.10) in the final psychiatric hospitalization collectively provided the p...Continue Reading

References

Feb 16, 2002·Heart·N T Mulvihill, J B Foley
Apr 30, 2003·Diabetes Care·Aaron I VinikRoy Freeman
Apr 9, 2004·The New England Journal of Medicine·John DaneshVilmundur Gudnason
Apr 17, 2004·Seminars in Neurology·Aaron I VinikTomris Erbas
Apr 9, 2005·The Journal of Clinical Psychiatry·Richard N Bergman, Marilyn Ader
Jun 29, 2005·Circulation·Peter Libby, Pierre Theroux
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
Sep 30, 2008·Psychoneuroendocrinology·Alexander HaenselJoel E Dimsdale
Jan 15, 2009·Journal of Clinical Psychopharmacology·Charlotte van NoordBruno H C Stricker
Oct 5, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Yana VinogradovaCatherine Penny
Oct 15, 2010·Journal of Psychopharmacology·Hiram Joseph Wildgust, Mike Beary
Jun 7, 2011·Biological Psychiatry·Brian J MillerBrian Kirkpatrick
Jan 18, 2012·Current Opinion in Psychiatry·Thomas M LaursenMogens Vestergaard
Apr 5, 2012·Journal of Psychopharmacology·Brian E LeonardAye Mu Myint
Nov 22, 2012·Nature Reviews. Endocrinology·Valentin A Pavlov, Kevin J Tracey
Jan 16, 2013·The American Journal of Psychiatry·Casey CrumpJan Sundquist
Feb 19, 2013·Cell·Andrew M F Johnson, Jerrold M Olefsky
Nov 13, 2013·Progress in Cardiovascular Diseases·Heikki V Huikuri, Phyllis K Stein
May 23, 2014·Journal of Psychiatric Practice·Asim A ShahJohn Coverdale
Jun 1, 2013·Acta Neuropsychiatrica·Hsin-An ChangSan-Yuan Huang

❮ Previous
Next ❯

Citations

Mar 22, 2018·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·A V SakharovM S Shvets
Jun 4, 2019·Zeitschrift für Psychosomatische Medizin und Psychotherapie·Dirk von Boetticher, Thomas Meyer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.